These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29199219)

  • 1. Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
    Morishita K; Shoji Y; Tanaka S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2017; 65(12):1144-1160. PubMed ID: 29199219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor γ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition.
    Otake K; Azukizawa S; Takeda S; Fukui M; Kawahara A; Kitao T; Shirahase H
    Chem Pharm Bull (Tokyo); 2015; 63(12):998-1014. PubMed ID: 26633022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Varshney K; Gupta AK; Rawat A; Srivastava R; Mishra A; Saxena M; Srivastava AK; Jain S; Saxena AK
    Chem Biol Drug Des; 2019 Jul; 94(1):1378-1389. PubMed ID: 30903642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
    Jiang B; Guo S; Shi D; Guo C; Wang T
    Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
    Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors.
    Campos-Almazán MI; Flores-Ramos M; Hernández-Campos A; Castillo R; Sierra-Campos E; Torgeson K; Peti W; Valdez-Solana M; Oria-Hernández J; Méndez ST; Castillo-Villanueva A; Jiménez-de Jesús H; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem; 2021 Oct; 48():116418. PubMed ID: 34563877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B.
    Kim DH; Paudel P; Yu T; Ngo TM; Kim JA; Jung HA; Yokozawa T; Choi JS
    Chem Biol Interact; 2017 Dec; 278():65-73. PubMed ID: 29031618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
    Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
    J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
    Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
    Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
    Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
    Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
    Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
    Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.
    Du Y; Ling H; Zhang M; Shen J; Li Q
    Bioorg Med Chem; 2015 Aug; 23(15):4891-4898. PubMed ID: 26100442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.